ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
701 hedge funds and large institutions have $22.4B invested in Alexion Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 122 funds opening new positions, 245 increasing their positions, 247 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1% less repeat investments, than reductions
Existing positions increased: 245 | Existing positions reduced: 247
19% less call options, than puts
Call options by funds: $305M | Put options by funds: $378M
Holders
701
Holding in Top 10
21
Calls
$305M
Puts
$378M
Top Buyers
| 1 | +$297M | |
| 2 | +$226M | |
| 3 | +$125M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$112M |
| 5 |
JPMorgan Chase & Co
New York
|
+$97.7M |
Top Sellers
| 1 | -$196M | |
| 2 | -$152M | |
| 3 | -$124M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$119M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$95.7M |